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Abstract
Objective: To explore the correlations between liver fat content and clinical index in patients with impaired glucose
tolerance (IGT) and healthy subjects.
Materials and Methods: 56 subjects were enrolled and each of them underwent upper-abdominal MRI examination that
involved a T1 VIBE Dixon sequence. 14 was clinically diagnosed with IGT (collectively as IGT group ) while 42 showed normal
glucose tolerance,(collectively as NGT group). NGT group was further divided into NGTFat (BMI$25, 18 subjects) and
NGTLean (BMI,25, 24 subjects). The total liver fat contents was measured and compared with clinical findings and
laboratory results in order to determine statistical correlations between these parameters. Differences among IGT, NGTFat
and NGTLean groups were evaluated.
Results: For all the subjects, fat volume fractions (FVFs) ranged from 4.2% to 24.2%, positive correlations was observed with
BMI, waist hip ratio(WHR), low density lipoprotein(LDL), fasting plasma insulin(FPI), homeostasis model assessment insulin
resistance (HOMA-IR) and homeostasis model assessment b(HOMAb). FVFs of IGT group (p = 0.004) and NGTFat group
(p = 0.006) were significantly higher than those of NGTLean group.
Conclusions: People with higher BMI, WHR and LDL levels tend to have higher liver fat content. Patients with BMI$25 are
more likely to develop IGT. Patients with higher FVF showed higher resistance to insulin, thus obtained a higher risk of
developing type 2 diabetes mellitus.
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Introduction
Ectopic fat deposition is commonly seen in many diseases,
especially in metabolic disorders, such as obesity, insulin
resistance, and other components of metabolic syndrome. It plays
an important role in the development and progression of
nonalcoholic fatty liver disease (NAFLD) [1–3]. It is thought to
have direct positive impact on the increasing rate of obesity and
NAFLD prevalence across the world [4]. According to some
researchers, about 10,20% patients with NAFLD are affected by
the progressive form of NAFLD, otherwise known as nonalcoholic
steatohepatitis (NASH) where 20,30% of patients with NASH
will develop cirrhosis and end-stage liver disease [5–7].
Liver fat content is an essential indicator for the progression of
NAFLD [8]. So far, many techniques and methods have been
developed for diagnosing fatty liver disease and quantifying liver
fat content. This can be achieved by techniques such as liver
biopsy/pathology, computed tomography (CT) scanning, ultra-
sound, and magnetic resonance imaging (MRI). However, all these
techniques have various shortcomings. For example, the gold
standard for assessing fat content in liver, biopsy/pathology, is
invasive and subjective to sampling error [9–12]. CT can only be
used to detect the existence of fat but not to measure the total
amount of the fat content. Furthermore, the accumulative
radiation exposure from repeated CT scans can be harmful which
limits its role in evaluating disease progression during long term
follow up. In comparison, Magnetic resonance (MR) spectroscopy
has been widely-applied and can provide accurate evaluation of
hepatic fat content, however, it is time consuming and evaluation
only limits to part of the liver [13–15].
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MR technique for quantifying fat content is based on chemical
shift imaging. It is one of the most promising techniques due to its
non-invasive, radiation-free and easy-to-perform characteristics
[14,16]. Dixon technique is a two-point chemical shift-based fat-
water separation method described by Dixon in 1984 [17]. It
acquires two images with different echo times (TE) to separate the
fat signals from the water signals in the same voxel (in-phase and
out-of-phase). Pure fat image and water image are obtained by the
following equation:
W~
SIPzSOP
2
F~
SIP{SOP
2
(W: water phase; F: fat phase; SIP: signal of in-phase; SOP:
signal of out-of-phase).
With this technique, the map of fat deposition in the liver can be
displayed, and the fat content across the entire liver can be
measured.
Clinical and laboratory parameters such as body mass index
(BMI), waist hip ratio (WHR), serum triglycerides (TG), and low
density lipoprotein (LDL) levels are thought to be related to extent
of fat accumulation in liver [18,19]. Accurate fat quantification of
the entire liver, and the investigations of the relationship between
liver fat content and clinical parameters may provide information
for future clinical interventions. This study aims to validate the use
of Dixon technique in total liver fat content quantification, as well
as to explore the correlations between liver fat content and clinical
paremeters in both healthy subjects and those with impaired
glucose tolerance.
Materials and Methods
Ethic statement
The study was conducted in accordance with ethical guidelines
for human research, the Health Insurance Portability and
Accountability Act (HIPAA) and was approved by the research
ethical committee of The First Affiliated Hospital of Sun Yat-sen
University. Written informed consent was obtained from all
patients, and legal guardian if the patients were younger than 18
years old. Permission was obtained from the hospital for the
publications of medical images seen in the Figures.
Phantom validation
We first evaluated the accuracy of the fat-quantifying technique
with some fat-water phantoms. Homogeneous emulsions consist-
ing of vegetable (peanut) oil and distilled water were prepared in
50 ml bottles, with fat volume fractions (FVF) of 0%, 10%, 20%,
30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, using a magnetic
stirrer hotplate heated to 50uC. Agar gel (2% by weight) and
dioctyl sulfosuccinate sodium salt (15 mmol/L) were added in
each bottle to stabilize the emulsions (Figure 1) [20]. All the bottles
were placed in a water tank with a temperature of 37uC (mimic the
temperature of normal human body).
MR images were obtained using a 3-Tesla whole-body human
MRI scanner (SIEMENS 3.0T MAGNETOM Verio). A head coil
was used and T1 volumetric interpolated breath-hold examination
(VIBE) Dixon sequence was applied with the following parame-
ters: TE, 2.5 ms, 3.7 ms; TR, 5.62 ms; flip angle, 5u; receiver
bandwidth, 6504.0 kHz; slice thickness, 3.0 mm. Four images of
the phantoms were generated, including in-phase and out-of-
phase, as well as fat and water phase images.
Subjects and clinical data
Fifty-six subjects were enrolled in the study. Oral glucose
tolerance test was conducted subjects were divided into either
impaired glucose tolerance (IGT) group or normal glucose
tolerance (NGT) group accordingly. 14 were clinically diagnosed
with impaired glucose tolerance (2 males, 12 females, age range
47,58 years old, average age was 53 years old) and 42 with
normal glucose tolerance (18 males, 24 females, age range 43,57
Figure 1. Results of phantom experiment. The bottle on the lower left side is filled with pure water (fat content: 0%), and the upper right one is
filled with 100% peanut oil, while others have fat content ranging from 10% to 90% in sequence. In the fat phase image, the higher the fat content is,
the higher signal intensity can be seen. But in water phase, the signal intensity of each bottle turned opposite to that of fat phase. The fat volume
fraction (FVF) map demonstrates clear differences for different amounts of fat and water through the change of color.
doi:10.1371/journal.pone.0111283.g001
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years old, average age 50 years old). Other clinical parameters and
laboratory tests were also measured: BMI, WHR, body fat content
(BFC), total cholesterol (CHOL), TG, LDL, fasting plasma insulin
(FPI), homeostasis model assessment IR (HOMA-IR), homeostasis
model assessmentb (HOMAb). NGT group was further divided
into two groups according to BMI: NGTFat group, BMI .25 (the
upper-limit in healthy people), 18 subjects (BMI: 26.661.4);
NGTLean group, BMI ,25, 24 subjects (BMI: 23.061.4). The
BMI of all 14 patients in IGT group were higher than 25(BMI:
28.062.2).
Figure 2. Irregular-shaped Regions of Interest (ROI) (1) covering the entire liver was placed in 21 consecutive slices (max-area
centered) on the fat volume fraction (FVF) map of a typical patient. The average FVF in the ROI was recorded.
doi:10.1371/journal.pone.0111283.g002
Figure 3. Correlation of actual fat volume fraction (FVF) of the water/fat phantoms against the mean fat fraction computed from
Dixon technique. The best-fit-line was displayed. (r2 = 0.994, p = 0.000).
doi:10.1371/journal.pone.0111283.g003
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Each subject underwent an upper-abdominal MRI examination
that involved an initial set of localizer images and then a T1 VIBE
Dixon sequence. The imaging parameters were the same as those
in the phantom study, with TE of 2.5/3.7 ms and TR of 5.47 ms.
All the subjects were imaged in supine position and carefully
instructed to breath hold during end inspiration to ensure
consistency amongst subjects. Four images, in-phase, out-of-phase,
fat-phase and water-phase, were obtained at the same time within
a single breath-hold for each patient.
MR Image post processing and analysis
Fat volume fraction (FVF) map was generated by combining the
MR images obtained during both fat-phase and water-phase of
each subject. This was done by using a newly designed plug-in
algorithm created under MATLAB platform (MATLAB r2011b,
Figure 4. FVF maps of two typical subjects from IGT group (A) and NGTLean group (B). A: a 58 years old female who was diagnosed as IGT
(BMI = 31.85), with a mean FVF of 24.23%. The fat phase and FVF map demonstrated that the deposition of fat is homogeneous. B: a 50 years old
female (BMI = 23.13) with a mean FVF of 4.15%. The color of the liver in case B is much darker than that in case A, indicating a lower fat content.
doi:10.1371/journal.pone.0111283.g004
Table 1. Correlations between the liver FVF values and clinical parameters in all subjects as determined by Spearman correlation
test.a.b
Variables Correlation Coefficient P
BMI 0.595 0.004
BFC 20.024 0.915
WHR 0.432 0.045
CHOL 0.352 0.108
TG 0.689 0.019
LDL 0.455 0.033
FPI 0.886 0.019
HOMA-IR 0.886 0.019
HOMAb 0.943 0.005
aFVFs have positive correlation with BMI, WHR, TG, LDL, FPI, HOMA-IR and HOMAb, while BFC and CHOL were found to have no statistical correlation with liver fat
content.
bFVF, fat volume fraction; BMI, body mass index; BFC, body fat content; WHR, waist hip rate; CHOL, cholesterol; TG, triglyceride; LDL, low density lipoprotein; FPI, fasting
plasma insulin; HOMA-IR, homeostasis model assessment insulin resistance; HOMAb, homeostasis model assessmentb.
doi:10.1371/journal.pone.0111283.t001
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MathWorks, America), using the following equation:
FVF~
F
WzF
|100%
(FVF: fat volume fraction; F: fat volume; W: water volume).
In phantom study, two trained radiologists manually traced a
round-shaped region of interest (ROI) on each bottle, and
recorded the results of FVFs. The diameter of ROI is 3 cm, the
size of the transverse section of the bottles. Average FVFs of each
bottle were acquired.
In vivo study, two trained radiologists manually placed an
irregular-shaped ROI covering the entire liver in 21 consecutive
slices (max-area centered) of each patient (Figure 2). The mean
FVF in the ROI of each subject was recorded.
Statistical analysis
FVF values were calculated using the Dixon technique and
compared to true FVFs in the phantom experiment using linear
correlation. In vivo study, statistical correlations between FVFs
and results of clinical and laboratory tests were determined by
using the Spearman’s rank correlation. The difference in FVF
between three groups was evaluated using the Wilcoxon test. A p
value lower than 0.05 was considered as statistically significant. All
the analyses were performed in SPSS (SPSS, Version 13.0,
Chicago, IL, USA).
Results
Phantom study
Figure 1 summarizes the results from the phantom study. The
bottle on the lower left side is filled will pure water (fat content:
0%), and the upper right one is filled with 100% peanut oil. Others
contain fat content ranging from 10% to 90%. During the fat
phase image, higher fat content was associated with a higher signal
intensity. The opposite was observed during the water phase
image where higher fat content was associated with a lower signal
intensity. FVF map demonstrated different amounts of water/fat
in the emulsions ranging from 0% to 100% with changing color. A
graph comparing the actual FVF against fat fraction calculated by
Dixon technique also showed excellent correlation (Figure 3,
r2 = 0.994, p = 0.000)). This result indicates that Dixon technique
is applicable for measuring the actual fat content of the liver.
In vivo results
For each subject, FVF maps were generated from the source
images of both fat phase and water phase. Figure 4 shows the FVF
maps of two typical subjects from IGT group (A) and NGTLean
group (B) respectively. The darker color of the liver seen in
Figure 4B indicates lower fat content in NGTLean group when
compared to the IGT group as seen in Figure 4A. Furthermore, in
both fat phase image and FVF map (Fig. 4A), the distribution of
fat in liver in people with metabolic disorders tended to be
homogeneous, which is different from fat accumulation caused by
inflammation [21].
For all the subjects, FVFs ranged from 4.2% to 24.2%, and had
positive correlation with BMI (p= 0.004), WHR (p= 0.045), TG
(p= 0.019), LDL (p= 0.033), FPI (p = 0.019), HOMA-IR
(p = 0.019) and HOMAb (p = 0.005) (Table 1, Spearman’s rank
correlation). For IGT group, FVFs positively correlated with FPI
(p = 0.019), HOMA-IR (p = 0.019), HOMAb (p = 0.005), while
the FVFs of healthy groups did not show significant correlation
with any of these clinical parameters.
FVFs of IGT group were significantly different from those of
NGTLean group (p = 0.004), but no significant difference was
found between IGT group and NGTFat group (p.0.05). FVFs of
NGTLean group were also significantly different from those of
NGTFat group (p= 0.006) (Figure 5).
Figure 5. Boxplots of FVF values for the IFT, NGTFat and NGTLean groups. Significant differences was found between IGT group and
NGTLean group (p = 0.004), as well as the NGTFat group and NGTLean group (p = 0.006). But there was no significant difference between IGT group
and NGTFat group (p = 0.359).
doi:10.1371/journal.pone.0111283.g005
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Discussion
The amount of the liver fat content is essential in monitoring the
progression of NAFLD and it acts as a potential indicator of
underlying metabolic disorders [22]. Unlike MR spectroscopy,
Dixon technique provides us with separate fat and water phase
images within a single breath-hold. Dxion technique is easier to
perform than MRS; and the image analysis is also more
straightforward. Liver fat content measurement and detection
using Dixon technique have been reported in previous studies [23–
27]. For example, D’Assignies, G. et al. have evaluated the ability
of MRS, Dixon technique and diffusion-weighted MR imaging
(DWI) to detect liver steatosis using histopathology as a reference
[23]. They have also evaluated the correlations between fat
fraction (FF) measured by MRS, Dixon technique and clinical
parameters such as LDL and cholesterol concentrations, which
showed consistent result with our study. However, their study
mainly focuses on the sensitivity, specificity and accuracy in
diagnosis of liver steatosis for three different noninvasive MR
techniques, MRS, Dixon technique and DWI. In another study,
Houchun H. Hu and colleagues have demonstrated a strong
potential for IDEAL technique (Iterative Decomposition with
Echo Asymmetry and Least squares estimation, a modified Dixon
technique) as a liver fat quantification tool and a valuable method
for obesity research [24]. However, in the studies mentioned
above, only a small oval- or square-shaped ROI on the liver was
studied, hence could not appropriately evaluate the total amount
of the liver fat content.
In this study, from the separate fat and water phase images, a
3D voxel-wise fat fraction map of the entire abdomen was
generated which showed the spatial pattern of ectopic fat, and
mean FVF of the entire liver on the map was calculated. For each
subject, 21 consecutive slices (max-area centered) of the FVF map
was used to generate the liver ROI, and the mean value was
recorded to stand for the FVF of this subject. Proved to be
dependable by the phantom study, FVFs obtained via the Dixon
technique is found to approximately equate to the actual fat
content throughout the liver. The spatial information of the liver
fat is also readily available (Fig. 1 and Fig. 4).
Under normal circumstance, liver plays an important role in the
lipid metabolism. It is involved in free fatty acid uptake from the
blood to synthesize TG, essential in the lipoprotein transportation
by combining different types of lipids with lipid-carrying protein.
When the efficiency of TG synthesis exceeds the transporting
capacity of lipoproteins, TG and other types of lipids accumulates
in the liver, resulting in fatty liver, or otherwise known as, ectopic
fat deposition [1,2]. Unlike fat accumulation resulted from
inflammation [21], people with metabolic disorders tend to have
homogeneous fat deposition, and this is demonstrated in the FVF
maps. Fat accumulation caused by acute hepatitis, for instance,
demonstrates focal fat content from local hepatocyte necrosis and
proliferation of fibrous connective tissue. However, fat accumu-
lation due to metabolism disorders is a systematic process, and has
no region-specific predisposition. Therefore, the possible cause of
liver fat deposition may be diagnosed based on the pattern of fat
distribution seen in FVF map.
In our study, it was found that FVFs have positive correlations
with many clinical and laboratory results such as BMI, WHR, TG
and LDL, which are consistent with some previous reports [18,19].
Besides, FVFs in IGT group is significantly higher than those of
NGTLean group, while there is no significant difference seen
between IGT group and NGTFat group. This indicates that fat
people (BMI$25) tend to have a higher fat content in liver due to
increased burden on the liver from high free fatty acids in the
blood. When the burden overwhelms the ability of processing fatty
acids in liver, the fat will gradually accumulate in liver and this
deposition may cause fatty liver diseases. In addition, high serum
free fatty acid will slow down the utilization of glucose and
stimulate the secretion of insulin. This leads to increased insulin
resistance over time, which may eventually progress into IGT.
Thus it is possible that the subjects of NGTFat group are at higher
risk of developing IGT than people with normal BMI. This can be
further supported by the lack of significant differences seen in lier
fat content between the IGT and NGTFat subjects where BMIs of
subjects in both groups were greater than 25.
On the other hand, we have found that liver fat content did not
statistically correlate with BFC. One possible explanation is that
high BFC does not equate to high viscera fat content, and the
latter contributes much more to the liver fat content than BFC.
Instead, WHR provided better reflection regarding the fat
distribution of the body. People with high WHR have more fat
deposition around the abdomen and in the viscera. Therefore, the
higher WHR, the higher viscera fat deposition, and the higher the
fat content in liver, as well.
This study also demonstrated that liver fat content has a positive
correlation with FPI, HOMA-IR and HOMAb. That means
people with higher liver fat content tend to have higher FPI,
HOMA-IR and HOMAb levels. FPI reflects the body’s sensitivity
to insulin. Higher FPI is associated with lower insulin sensitivity.
HOMA-IR can be calculated from FPI, which reflects insulin
resistance. Thus, our results may indicate that people with high
HOMA-IR levels are more resistant to insulin. Insulin resistance is
recognized as a main risk factor for many metabolic disorders, and
it especially increases the probability to develop type 2 diabetes
[28]. In our study, FVFs of IGT group was positively correlated
with FPI and HOMA-IR. In other words, IGT patients with
higher FVFs are more resistant to insulin, and may have a higher
risk to develop type 2 diabetes mellitus. Therefore, fat content
quantification using Dixon technique has its value as a prognostic
tool for IGT patients.
To summarize, this study has verified an accurate, noninvasive
and easy-to-perform method based on Dixon technique to
quantify the fat content across the entire liver. FVF calculated
with the technique reflects the actual liver fat content. The
significant correlations of FVF with some other clinical parameters
indicate further investigations are necessary for the epidemiology
and pathophysiology of NAFLD as well as other metabolism
disorders.
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